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Summary 
Prion diseases are a unique group of transmissible, chronic, neurodegenerative 
disorders.  Following peripheral exposure (eg: oral), prions often accumulate first 
within the secondary lymphoid tissues before they infect the central nervous 
system (CNS).  Prion replication within secondary lymphoid tissues is crucial for 30 
the efficient spread of disease to the CNS.  Once within the CNS, the responses 
of innate immune cells within it can have a significant influence on 
neurodegeneration and disease progression.  Recently there have been 
substantial advances in our understanding of how cross-talk between the host and 
the vast community of commensal microorganisms present at barrier surfaces 
such as the gut, influence the development and regulation of the host’s immune 
system.  These effects are evident not only in the mucosal immune system in the 
gut, but also in the CNS.  The actions of this microbial community (the microbiota) 
have many important beneficial effects on host health, from metabolism of 
nutrients and regulation of host development, to protection from pathogen 40 
infection.  However, the microbiota can also have detrimental effects in some 
circumstances.  In this review we discuss the many and varied interactions 
between prions, the host and the gut microbiota.  Particular emphasis is given to 
the ways by which changes to the composition of the commensal gut microbiota 
or congruent pathogen infection may influence prion disease pathogenesis and/or 
disease susceptibility.  Understanding how these factors influence prion 
pathogenesis and disease susceptibility is important for assessing the risk to 
infection and the design of novel opportunities for therapeutic intervention.   
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Abbreviations: BSE, bovine spongiform encephalopathy; CJD, Creutzfeldt-Jakob 
disease; CNS, central nervous system; CWD, chronic wasting disease; FDC, 
follicular dendritic cell; GALT, gut-associated lymphoid tissue; ILF, isolated 
lymphoid follicle; MNP, mononuclear phagocytes; PrP, prion protein; SCFA, short 
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INTRODUCTION 60 
Prion diseases, or transmissible spongiform encephalopathies, are sub-acute 
neurodegenerative diseases which affect humans and certain domestic and free-
ranging animal species (Table 1).  Prion diseases are characterized by the 
presence of aggregations of PrPSc, an abnormally folded isoform of the host-
encoded cellular prion protein (PrPC), in affected tissues (Bolton et al., 1982, 
Prusiner et al., 1982).  Prions are unique amongst infectious agents in that they 
appear to lack nucleic acid, comprising solely of the PrPSc protein (Legname et al., 
2004, Wang et al., 2010).  The accumulation of PrPSc in the central nervous system 
(CNS) of prion-infected hosts is accompanied by reactive microglial and astroglial 
responses, and significant levels of neurodegeneration.  A diverse range of cellular 70 
functions have been ascribed to the cellular PrPC protein including maintenance of 
circadian rhythms (Tobler et al., 1996), signal transduction (Spielhaupter & 
Schatzl, 2001), seizure sensitivity (Walz et al., 1999), cognition (Coitinho et al., 
2003), maintenance of peripheral myelin (Bremer et al., 2010) and phagocytosis 
of apoptotic cells (de Almeida et al., 2005).  However, the precise physiological 
role remains controversial as some, with the exception of peripheral myelin 
maintenance, have been since shown to be due to consequences of flanking gene 
issues or spurious overexpression of Doppel protein in certain PrP-deficient mouse 
lines (Nuvolone et al., 2016, Nuvolone et al., 2013, Steele et al., 2007).   
 Some prion diseases have an idiopathic aetiology, apparently arising 80 
spontaneously within the CNS (eg: sporadic Creutzfeldt-Jakob disease; CJD).  
Others such as Gerstmann-Straussler-Scheinker syndrome are associated with 
polymorphisms within the PRNP gene (which encodes PrPC), which may 
predispose PrPC to abnormally fold into the pathogenic isoform, whereas other 
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polymorphisms may protect against disease transmission (Asante et al., 2015).  
Many other prion diseases are acquired, such as following oral consumption of 
prion-contaminated food.  These include natural sheep scrapie, bovine spongiform 
encephalopathy (BSE), chronic wasting disease (CWD) in cervid species such as 
deer and elk, and variant Creutzfeldt-Jakob disease (vCJD) in humans (Table 1).   
The gut-associated lymphoid tissues (GALT) are a group of multi-follicular 90 
structures including the tonsils, Peyer’s patches, appendix, colonic and caecal 
patches, as well as individual follicular structures termed isolated lymphoid follicles 
(ILF).  GALT occur throughout the gastrointestinal tract and along with the 
mesenteric lymph nodes help maintain homeostasis within the gut and protect the 
host from pathogen infection.  After oral exposure the replication of prions within 
Peyer’s patches in the small intestine is crucial for their efficient transmission to 
the CNS (termed neuroinvasion) (Donaldson et al., 2015b).  Within them, the 
prions replicate upon the surfaces of stromal-derived follicular dendritic cells (FDC) 
located within the B-cell follicles (Mabbott et al., 2000, Mabbott et al., 2003, 
McCulloch et al., 2011, Montrasio et al., 2000). The prions then infect neighbouring 100 
enteric nerves, and spread from them via the sympathetic and parasympathetic 
nervous systems to the CNS where they cause neurodegeneration and the 
eventual death of the host (Beekes & McBride, 2000, Glatzel et al., 2001, Kujala 
et al., 2011, McBride et al., 2001). 
The mammalian gastrointestinal tract is home to a vast community of 
commensal microorganisms, termed the microbiota (Sommer & Backhead, 2013), 
and the colon of a typical 70 kg human male is estimated to harbour approximately 
3.9 x 1013 bacteria (Sender et al., 2015).  The commensal gut microbiota provides 
many beneficial effects on host health including metabolizing nutrients (Russell et 
6 
 
al., 2013), influencing the development and regulation of the immune system 110 
(Furusawa et al., 2013, Hooper et al., 2012), as well as outcompeting pathogens 
for nutrients or habitats (Kamada et al., 2012).  Rapid advances in high-throughput 
sequencing technology have helped to gain a greater understanding of the true 
abundance and complexity of the commensal microbiota (Claesson & O'Toole, 
2010).  This in-turn has helped reveal how factors such as diet, host genotype 
(Carmody et al., 2015), antibiotic use (Gibson et al., 2015), pathogen infection 
(Holm et al., 2015), host age and even the residential environment (Claesson et 
al., 2012) can affect both the composition of the gut microbiota and host health.   
Disturbances to the abundance and complexity of the microbiota can 
dramatically affect immune regulation and function, and are contributory factors in 120 
the development of some inflammatory and autoimmune diseases (Frank et al., 
2007).  These influences extend far beyond the GALT which have a close physical 
relationship with the microbiota.  Remarkably, the gut microbiota can also affect 
the development of the CNS.  The gut microbiota of mice can influence the 
development of certain neuronal circuits such as those involved in anxiety-like 
behaviour (Sudo et al., 2004), and constitutively controls the maturation and 
function of microglia within the CNS (Erny et al., 2015) (discussed below).  
Furthermore, diet-induced increases in bacteria from the order Clostridiales and a 
decrease in Bacteroidales, are associated with poor cognitive flexibility 
(Magnusson et al., 2015).   130 
In this review we discuss how imbalances to the composition or abundance 
of the host commensal microbiota, or congruent pathogen infection, may influence 
prion disease pathogenesis and susceptibility.   
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Effect of changes to the abundance and complexity of the gut microbiota on 
prion disease 
Effects on oral prion disease pathogenesis:  Cross-talk between the host 
immune system and the microbiota is critical for the development of the immune 
system, especially the GALT, which can in-turn regulate the microbiota.  At the 
time of writing this review there were no published studies which had directly 140 
addressed the influence of the commensal gut microbiota on oral prion disease 
pathogenesis.  Therefore, discussed below are studies which help to shed light on 
the effects that disturbances to the commensal gut microbiota may have.   
A dramatic reduction in the microbiota at the time of oral prion exposure 
could potentially impede disease pathogenesis.  One pronounced effect that the 
gut microbiota has on the host is the dynamic regulation of ILF development in the 
intestine (Donaldson et al., 2015a, Hamada et al., 2002) (Fig. 1).  ILF are inductive 
sites for immunoglobulin-A production and can be classified as either immature 
ILF (primary B-cell follicles), or mature ILF containing a single organized germinal 
centre, with a network of FDC and an overlying epithelium containing M cells 150 
(Donaldson et al., 2015a, Glaysher & Mabbott, 2007a, Lorenz et al., 2003).  ILF 
abundance is reduced in the small intestines of germ-free mice (which lack a gut 
microbiota), whereas ILF development is induced upon microbial colonisation 
(Donaldson et al., 2015a).  Our data show that ILF are important sites of prion 
accumulation and neuroinvasion in the small intestine (Donaldson et al., 2015b, 
Glaysher & Mabbott, 2007b).  Furthermore, oral prion disease susceptibility is 
reduced in the specific absence of GALT (ILF or Peyer’s patches) in the small 
intestine (Donaldson et al., 2015b, Glaysher & Mabbott, 2007b, Horiuchi et al., 
2006, Prinz et al., 2003).  These observations suggest that a microbiota-induced 
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reduction in ILF density in the small intestine could impede disease pathogenesis 160 
by reducing the available sites of prion uptake, replication and neuroinvasion in the 
gut.   
Unlike in the small intestine where the microbiota promotes ILF 
development, the microbiota inhibits ILF development in the large intestine (Fig. 1) 
(Donaldson et al., 2015a).  However, our experiments in mice show that large 
intestinal GALT are not important sites of prion neuroinvasion after oral exposure 
(Donaldson et al., 2015a).  Furthermore, an increased density of ILF specifically in 
the large intestine does not influence oral prion disease pathogenesis or 
susceptibility (Donaldson et al., 2015b).  Large intestinal GALT are also not 
considered to be important early sites of prion accumulation in humans exposed 170 
to vCJD (Hill et al., 1999, Peden et al., 2004), sheep with natural scrapie and BSE 
(van Keulen et al., 2008a, Van Keulen et al., 2008b) and cervids with CWD 
(Spraker et al., 2006, Spraker et al., 2009).  The early accumulation of prions in 
the ileal Peyer’s patches of cattle experimentally exposed to BSE has also been 
described (Katz et al., 2012).   
Pathogen infection can also disturb the composition of the commensal gut 
microbiota.  For example, a chronic infection of mice with the large intestinal 
nematode Trichuris muris decreases bacterial diversity, and increases the relative 
abundance of Lactobacillaceae (Holm et al., 2015) (Fig. 2).  However, congruent 
infection with T. muris at the time of oral prion exposure does not influence disease 180 
pathogenesis (Donaldson et al., 2015b) (Table 2).  Therefore, unlike in the small 
intestine where microbiota-mediated changes to GALT status may influence 
disease susceptibility, these data suggest that alterations to the abundance or 
diversity of the commensal microbiota in the large intestine at the time of oral prion 
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exposure are unlikely to have a significant impact on disease pathogenesis and 
susceptibility.  However, this issue is not straightforward as a dramatically reduced 
gut microbiota has other important effects on the host.  Germ-free mice display 
substantially enlarged caeca, reduced spleen size (Reikvam et al., 2011) and 
altered gastrointestinal motility and transit time (Kashyap et al., 2013).  Each of 
these could potentially influence oral prion disease pathogenesis.   190 
 
Effects on CNS prion disease:  A bidirectional communication system, termed 
the gut-brain axis, integrates neural, hormonal and immunological signalling 
between these two distantly situated tissues.  This enables the brain to influence 
a variety of physiological activities in gut including motility and secretion, and the 
actions of the mucosal immune system (Collins et al., 2012).  Conversely, gut- and 
microbiota-derived products can also influence the brain, for example, through the 
release of cytokines, hormones such as 5-hydroxytryptamine or stimulation via 
afferent neural pathways of the vagus nerve and spinal cord.  These in-turn can 
influence the composition of the gut microbiota, either directly, or due to 200 
physiological effects on the intestine.   
Once the prions enter the CNS they cause extensive neuropathology which 
is characterised by the activation of microglia and astrocytes, accumulations of 
PrPSc and neurodegeneration (Fig. 3).  Microglia are the tissue macrophages of 
the CNS and play important roles in maintaining neuronal homeostasis, synaptic 
remodelling, the removal of dead and dying cells and as a first line of defence 
against pathogens (De Lucia et al., 2015, Kranich et al., 2010, Prinz & Priller, 2014, 
Zhan et al., 2014).  A change in microglial status from resting to activated is one 
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of the first pathological features observed in the CNS during prion disease and 
occurs long before the development of neuropathology (Vincenti et al., 2016). 210 
This activation is characterised by increased expression of the anti-
inflammatory cytokines TGF-β and PGE2, signalling receptors including Trem2, 
SiglecF, CD200R, and Fcγ receptors, and the development of a highly branched 
morphology (Lunnon et al., 2011).  These are characteristic of an anti-inflammatory 
profile such as that exhibited by macrophages following their engulfment of 
apoptotic cells (Fadok et al., 1998).  Thus instead of triggering neurodegeneration, 
the microglial response during prion disease may play an important 
neuroprotective or pro-neurogenic role in response to the damage caused by the 
infection (De Lucia et al., 2015).  In support of this hypothesis, prion pathogenesis 
is accelerated when microglia are unable to sequester apoptotic cell remnants as 220 
in MFGE-8-deficient mice (Kranich et al., 2010), and delayed in mice deficient in 
CD14 (a component of the LPS receptor), where increased microglial activation 
and enhanced expression of anti-inflammatory cytokines such as IL-10 is observed 
during the preclinical phase (Sakai et al., 2013).  Thus, alterations to this 
phenotype, through the sensing of bacterial LPS from commensal bacteria, could 
be sufficient to modify the anti-inflammatory/neuroprotective status of microglia 
during CNS prion disease towards a more pro-inflammatory disease-exacerbating 
phenotype.   
Exciting data show that the development and function of microglia in the 
CNS is controlled by the gut microbiota.  Microglial maturation is compromised in 230 
the brains of germ-free mice and coincides with reduced early responses to LPS 
or virus infection (Erny et al., 2015).  A similar impairment to microglial 
development and function after treatment of conventionally-housed SPF mice with 
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broad-spectrum antibiotics (cefotoxin, gentamicin, metrinodazole and 
vancomycin), revealed that the gut microbiota constitutively maintains the 
homeostasis of microglia under steady-state conditions (Erny et al., 2015).  Similar 
effects were also observed following a 4 week treatment of conventional mice with 
broad-spectrum antibiotics (Erny et al., 2015).  These data imply that reductions to 
the complexity or abundance of the microbiota during CNS prion disease, such as 
prolonged use of broad-spectrum antimicrobial treatments, could affect the 240 
activation status of microglia and in doing so impair the development of 
neuropathology.   
Although originally undertaken over 40 years ago to address a separate 
issue (to define the nature of the scrapie agent), prion disease pathogenesis has 
been studied in germ-free mice (Lev et al., 1971).  Conventional mice and germ-
free mice were each injected intracerebrally with the Chandler mouse-adapted 
scrapie isolate (50 µl of 10% scrapie brain homogenate which had been 
lyophylized and irradiated at 6 M Rad to eliminate contaminating bacteria and 
viruses).  Survival times were apparently extended in germ-free recipients when 
compared to conventional mice.  On face-value these data appear to support our 250 
suggestion above that the impaired status of microglia in germ-free mice (Erny et 
al., 2015) might impede CNS prion pathogenesis.  However, it is uncertain from 
data presented whether this effect was significant (Lev et al., 1971) (Table 3).  
Furthermore, a subsequent study by Wade and colleagues did not observe a 
difference in survival time after intracerebral injection of ME7 scrapie prions into 
germ-free mice, but a prolongation was observed after intraperitoneal exposure 
(Wade et al., 1986) (Table 3).  The inconsistencies between these studies are 
difficult to explain.  However, it is noteworthy that in the Wade study the effects on 
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prion pathogenesis in germ-free were compared to those colonized with a 
restricted, defined Gram-positive bacterial flora comprising of particular species of 260 
Clostridium, Bacillus, Lactobacillus and Bacteroides.  This may have particular 
importance as the microglia in the brains of germ-free mice colonized with three 
strains of the altered Schaedler flora (Bacteroides distasonis, strain ASF 519; 
Lactobacillus salivarius, strain ASF 361; Clostridium cluster XIV, ASF 356) also 
display an immature phenotype (Erny et al., 2015).   
The treatment of hamsters with tetracycline antibiotics (doxycycline, 
tetracycline or minocycline) increased survival time when administered prior to or 
at the appearance of clinical signs of prion disease (De Luigi et al., 2008), similarly 
supporting the hypothesis that microbiota-mediated impairments to microglia 
status (Erny et al., 2015) might impede CNS prion pathogenesis.  In contrast, data 270 
from a clinical trial show that the daily treatment of clinical CJD patients with 
doxycycline did not significantly affect disease progression (Haik et al., 2014).  
However, it is difficult to determine a direct role for the effect of these antibiotics 
on the microbiota in these studies as tetracyclines can also inhibit PrPSc conversion 
and prevent neurotoxicity in cultured neurons (Tagliavini et al., 2000).   
 
Dietary effects on the microbiota:  Many mammalian species rely on 
constituents of the gut microbiota to break down indigestible dietary components. 
For example, Bacteroidetes and Clostridia metabolise the polysaccharides in 
dietary fibre into short chain fatty acids (SCFA).  Of these, butyrate plays an 280 
important role in regulating inflammation and maintaining the mucosal barrier 
(Furusawa et al., 2013), and the regulation of microglial homeostasis in the CNS 
(Erny et al., 2015).  The administration of SCFA to germ-free mice restores 
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microglial development, whereas GPR43-deficient mice, which lack the receptor 
for these SCFA, have severely malformed microglia (Erny et al., 2015).  The 
“Western diet” is typically high in fat and simple carbohydrates, and can 
dramatically and rapidly alter the microbiota composition (Turnbaugh et al., 2009), 
increasing the abundance of Firmicutes, and decreasing the abundance of 
Bacteroidetes which are important providers of SCFA (Magnusson et al., 2015, 
Turnbaugh et al., 2009).  Thus, Western diet-induced changes to the microbiota 290 
could reduce the availability of microbial metabolites such as SCFA, and in doing 
so, impair microglial development and function, influencing CNS prion disease.  
Although undertaken for a separate issue, the effects of a high-fat diet on CNS 
prion pathogenesis have been addressed (Zhu et al., 2015), but no significant 
effects on prion disease progression, PrPSc deposition in the brain, astrogliosis or 
microglial activation were observed.   
Although further studies are necessary to reconcile certain discrepancies 
between studies, the available data suggest that dramatic changes to the 
abundance or complexity of the commensal gut microbiota have the potential to 
modify the development and function of microglia, and in doing so, influence CNS 300 
prion pathogenesis.   
 
Direct effects of the gut microbiota on prions 
The disease-specific isomer of the prion protein, PrPSc, accumulates in affected 
tissues in insoluble aggregates that are relatively resistant to proteinase digestion 
and can transmit disease to recipients (Bolton et al., 1982, Prusiner et al., 1982).  
When prions are shed into the environment, they can bind to soil particles and can 
remain infectious for long periods (Bartelt-Hunt & Bartz, 2013).  Despite this 
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resilience ovine alimentary fluids appear to have sufficient proteolytic capacity to 
digest disease-specific PrP derived from sheep scrapie or BSE (Dagleish et al., 310 
2010, Jeffrey et al., 2006).  However, BSE agent-derived PrPSc can survive 
incubation with bovine ruminal and colonic microbiota preparations (Bohnlein et 
al., 2012) or raw sewage (Maluquer de Motes et al., 2012).  Whether effects on 
prion infectivity mirror these observations is uncertain, as bovine ruminal and 
colonic microbiota preparations can degrade hamster 263K prion-derived PrPSc, 
but prion infectivity is retained (Scherbel et al., 2006, Scherbel et al., 2007).  While 
the combined actions of host and microbiota-derived proteolytic enzymes may 
contribute to the partial digestion of certain prion isolates in the gut lumen, 
detectable levels of infectious prions can survive these processes and are secreted 
in the faeces of BSE-, CWD- and scrapie-infected hosts (Kruger et al., 2009, 320 
Maluquer de Motes et al., 2008, Safar et al., 2008, Tamguney et al., 2009), and 
can survive passage through the gastrointestinal tracts of coyotes (Canis latrans) 
(Nichols et al., 2015) and crows (VerCauteren et al., 2012).  One study has also 
proposed that bacterial components, such as LPS, may potentially enhance the 
abnormal folding of recombinant PrP (Saleem et al., 2014). 
 
Effects of congruent gastrointestinal pathogen infection on prion disease 
pathogenesis 
Effects on CNS prion disease:  Congruent infection with a gastrointestinal 
pathogen and systemic inflammation can each dramatically influence the 330 
progression of certain neurodegenerative diseases.  For example, systemic 
inflammation has also been associated with increased cognitive decline in 
Alzheimer disease (Holmes et al., 2009), and in pregnant mothers can promote 
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abnormal cortical development in their offspring (Choi et al., 2016).  A Th1-
polarized systemic immune response following infection with the large intestine-
restricted helminth T. muris can exacerbate ischemic brain damage in a stroke 
model (Denes et al., 2010).  Conversely, helminth-infections may also have 
beneficial effects and modulate immune responses and disease severity in multiple 
sclerosis patients (Correale & Farez, 2013).   
The anti-inflammatory cytokine milieu in the brain during prion disease, 340 
characterised by elevated expression of TGF-β, acts to regulate the microglial 
response to minimize CNS inflammation (Cunningham et al., 2002).  Consistent 
with this hypothesis are the demonstrations that CNS prion disease pathogenesis 
is exacerbated in the absence of typical anti-inflammatory cytokines, including IL-
4, IL-10 and IL-13 (Tamguney et al., 2008, Thackray et al., 2004).  However, the 
microglia can switch to a more pro-inflammatory profile upon systemic pathogen 
infection or exposure to pathogen-associated molecular patterns such as bacterial 
LPS (Combrinck et al., 2002, Cunningham et al., 2005, Lunnon et al., 2011).  
These changes to microglial status acutely exaggerate the cognitive decline, 
impair motor coordination and accelerate CNS prion disease progression 350 
(Combrinck et al., 2002, Cunningham et al., 2009, Cunningham et al., 2005).   
 
Effects on prion uptake and neuroinvasion from the lumen of the small 
intestine 
A congruent gastrointestinal pathogen infection may have a wide range of effects 
on oral prion disease pathogenesis and susceptibility.  For example, lesions to the 
mucosa can enhance the oral transmission of prions (Denkers et al., 2011).  
Pathogen exposure can also modify the expression of PrPC and innate immunity 
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genes in the gut mucosa (Dervishi et al., 2015, Sigurdson et al., 2009).  Therefore, 
gastrointestinal pathogen-mediated damage to the gut mucosa may exacerbate 360 
disease pathogenesis by enhancing prion uptake from the lumen.  Increased 
damage to the gut epithelium may also exacerbate the amount of prions shed into 
the environment (Bessen et al., 2012).  Discussed below are the many ways in 
which a congruent gastrointestinal pathogen infection may affect oral prion disease 
pathogenesis and susceptibility.   
 
Effects on M cells: The majority of the epithelial cells in the lining of the intestine 
function to absorb nutrients from the lumen.  However, M cells within the epithelia 
overlying the GALT, are specialized to acquire and transfer particulate microbial 
antigens across the intestinal epithelium (termed transcytosis).  The transcytosis 370 
of particulate antigens by M cells is important for their delivery to other immune 
cells in the GALT for the induction of efficient mucosal immune responses (Mabbott 
et al., 2013).  M cells are also important early sites of prion uptake from the 
intestinal lumen, and oral prion disease susceptibility is reduced in their absence 
(Donaldson et al., 2012, Heppner et al., 2001, Takakura et al., 2011).  Infection 
with pathogenic microorganisms such as Salmonella or stimulation from pathogen-
derived effector molecules such as cholera toxin enhance the density of M cells in 
the intestinal epithelium (Savidge et al., 1991, Tahoun et al., 2012, Terahara et al., 
2008).  Thus an increased abundance of M cells in the gut epithelium as a 
consequence of a congruent pathogen infection could enhance the uptake of 380 
prions from the gut lumen and increase disease susceptibility.   
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Effects on mononuclear phagocytes (MNP):  After transcytosis into GALT by M 
cells, the prions are then conveyed to the FDC within the B-cell follicles.  The 
mechanism by which this occurs is uncertain, but the prions are subsequently 
acquired by MNP (a heterogeneous population of macrophages and classical 
dendritic cells) in the underlying sub-epithelial dome region (Kujala et al., 2011).  
These MNP have been proposed to act as “Trojan horses” and shuttle prions 
towards the FDC (Huang et al., 2002, Mabbott & Bradford, 2015, Raymond et al., 
2007).  In the steady state the MNP are typically restrained within the lamina 390 
propria of the gut (the thin layer of connective tissues immediately beneath the 
epithelium) (Fig. 4a&b).  However, the presence of certain pathogenic 
microorganisms such as Salmonella or Aspergillus within the lumen of the small 
intestine stimulates the recruitment of MNP to the epithelium where they open the 
tight junctions between epithelial cells and insert their dendrites directly into the 
lumen to sample the contents (Farache et al., 2013, Niess et al., 2005, Rescigno 
et al., 2001, Vallon-Eberhard et al., 2006) (Fig. 4c).  Thus, the enhanced uptake of 
lumenal antigens in response to congruent pathogen infection in the small intestine 
may enhance the uptake of prions from the gut lumen, increasing disease 
susceptibility.   400 
In the absence of tissue macrophages the accumulation of prions in the 
Peyer’s patches (Maignien et al., 2005) and spleen is enhanced (Beringue et al., 
2000), suggesting that some MNP populations play a protective role by degrading 
prions (Macpherson et al., 2004).  Therefore, a significant influx of macrophages 
into the lamina propria of intestine, as occurs in response to certain pathogen 
infections (deSchoolmeester et al., 2003, Little et al., 2005) (Fig. 5b), could 
increase disease susceptibility by enhancing prion sequestration.   
18 
 
 
Congruent pathogen infection in the large intestine 
Although prions do not accumulate within the large intestinal GALT during the early 410 
stages of infection (Donaldson et al., 2015b, Gonzalez et al., 2009, Thomsen et 
al., 2012, van Keulen et al., 2000), pathogen-induced pathology in the large 
intestine might influence disease susceptibility by enhancing the uptake of prions 
into GALT within it.  Infection with the helminth T. muris is entirely restricted to the 
caecum and proximal colon (Fig. 5).  We reasoned that pathology caused by T. 
muris as it burrows within the gut epithelium (Wakelin, 1967) could increase 
disease susceptibility by increasing the uptake of prions (Fig. 5a).  Expulsion of the 
parasite at the later stages of infection coincides with the influx of large numbers 
macrophages into the lamina propria of the caecum (deSchoolmeester et al., 2003, 
Little et al., 2005) (Fig. 5b).  This might decrease oral prion disease susceptibility 420 
due to the increased sequestration of prions by macrophages (see above).  T. 
muris infection also stimulates ILF development in the large intestine (Donaldson 
et al., 2015b, Little et al., 2005) (Fig. 5c).   However, pathogen infection in the large 
intestine did not significantly affect survival time after oral prion exposure, 
irrespective of the time at which mice were co-exposed with prions in relation to 
the T. muris infection (Donaldson et al., 2015b) (Table 2). 
 An independent study has reported that congruent infection with S. 
Typhimurium exacerbated oral prion disease (Sigurdson et al., 2009).  In this study 
the effects on prion disease pathogenesis were attributed to the acute 
inflammation that infection with the bacterium causes in the colon.  However, 430 
whereas T. muris infection in mice is entirely restricted to the caecum, as 
discussed above, S. Typhimurium infection can affect M cells (Tahoun et al., 2012) 
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and MNP (Farache et al., 2013, Rescigno et al., 2001, Vallon-Eberhard et al., 
2006) in the small intestine which have key roles in oral prion disease 
pathogenesis.  Thus although these data appear to contradict those describing the 
effects of T. muris infection on oral prion disease pathogenesis (Donaldson et al., 
2015b), congruent S. Typhimurium infection may also have enhanced the uptake 
of prions from the small intestine.   
 
Changes to the microbiota in other tissues 440 
Mammary gland and mastitis:  The lactating mammary gland and breast milk 
contain complex ecosystems of commensal bacteria including Firmicutes, 
Bacteroidetes, Actinobacteria, and Proteobacteria (Jeurink et al., 2013).  Chronic 
inflammatory conditions such as mastitis can induce the extravasation of 
inflammatory lymphocytes and leukocytes, and the formation of ectopic germinal 
centres containing FDC in the inflamed tissue (Gommerman & Browning, 2003).  
The ectopic lymphoid follicles within the mammary glands of sheep with mastitis 
and coincident scrapie infection can act as ectopic sites of prion replication (Ligios 
et al., 2005).  Furthermore, scrapie-affected sheep with congruent lentiviral mastitis 
secrete prions into their milk at levels sufficient to transmit disease to suckling 450 
lambs (Ligios et al., 2011).   
 
Influence of prion disease on the gut microbiota 
At the time of writing we were not aware of any published data describing the 
effects of prion infection on the gut microbiota.  Clinically-affected individuals often 
display loss of appetite, dehydration, constipation and abnormal faecal transit time 
during the clinical phase.  This could dramatically alter the diversity of the 
20 
 
microbiota in clinically affected individuals.  However, whether this influences the 
progression or onset of clinical signs remains to be determined and will depend on 
the magnitude and nature of the microbial species affected.   460 
 
Concluding remarks 
In this review we have drawn together data from a wide range of studies, which 
directly or indirectly, enable us to assess how changes to the gut microbiota could 
influence prion disease pathogenesis and susceptibility.  Although further studies 
are necessary to resolve certain discrepancies, or address important knowledge 
gaps, the available data suggest that dramatic changes to the abundance or 
complexity of the commensal gut microbiota (eg: after prolonged use of antibiotics) 
have the potential to modify the development and function of microglia, and in 
doing so, influence CNS prion pathogenesis.  Studies have also shown that a 470 
congruent pathogen infection or systemic inflammation can dramatically alter prion 
disease progression and susceptibility.  Within the CNS these effects appear to be 
mediated through the modification of the microglial response to the prion infection.  
Whereas in the intestine, data suggest that congruent pathogen infection in the 
small intestine may enhance the uptake of prions from the gut lumen.  Pathogen-
mediated pathology specifically in the large intestine, in contrast, has little effect 
on prion pathogenesis.    
Following the emergence of BSE in the 1980s estimates suggest more than 
500,000 infected cattle may have entered the UK food chain (Valleron et al., 2001, 
Wilesmith, 1993).  Despite this apparent widespread exposure of the UK 480 
population to the BSE agent through the food chain the number of confirmed 
clinical cases of vCJD fortunately remains low (Bishop et al., 2013).  However, 
21 
 
data from the retrospective analyses of PrPSc accumulation in archived 
appendiceal samples (Gill et al., 2013) suggest that the prevalence of vCJD 
infection may be much higher.  This implies the potential existence of a subclinical 
carrier state (Clewley et al., 2009, Garske & Ghani, 2010).  Understanding how 
this preclinical phase is maintained will be important to determine the factors which 
influence the risk of developing clinical prion disease, and the design of novel 
opportunities for therapeutic intervention.  Thus, it will be important to determine 
whether factors such as dramatic changes to the commensal microbiota (such as 490 
use of broad-spectrum antibiotics or dietary changes) or congruent pathogen 
infection can enhance disease progression in these subclinical individuals.   
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Figure legends 
Fig. 1. Effects of the microbiota on isolated lymphoid follicle (ILF) development in 
the intestine.  a) ILF abundance is reduced in the small intestines of germ-free 
mice, whereas their development is induced upon microbial colonisation.   This 
contrasts the situation in the large intestine where the microbiota suppresses ILF 
development.  Tissues were whole-mount immunostained to detect B cell-960 
containing ILF (B220, green) and CD35 (red) to detect FDC-containing mature ILF.  
White arrowheads, immature ILF; red arrowheads, mature ILF; Bar = 500 µm.  b) 
Total number of ILF in the ileum of the small intestines of germ-free and 
conventionalised mice.  Data adapted from Donaldson et al. (Donaldson et al., 
2015a).  c) Peyer’s patches and mature FDC-containing ILF in the small intestine 
are important early sites of prion accumulation after oral exposure.  Within these 
tissues, high levels of disease-specific PrP (PrPd, brown) are detected in 
association with FDC (CD21/35, brown).  Treatment of adjacent sections with 
proteinase K indicates the presence of relatively proteinase-resistant, prion-
specific PrPSc (blue/black).   Images adapted from Donaldson et al. (Donaldson et 970 
al., 2015b), copyright © American Society for Microbiology, J. Virol. (2015) 
89:9532–9547. doi:10.1128/JVI.01544-15. 
 
Fig. 2. A chronic Trichuris muris infection in mice dramatically alters the 
composition of the commensal gut microbiota.  (A) Bacterial taxa ploys showing 
the family level changes in the composition of the microbiota within faeces at 
intervals up to 35 days after T. muris infection. (B) Comparison of the composition 
of the microbiota in faeces and the caeca of naïve mice and at 35 days after T. 
muris infection.  This figure is reproduced from Holm et al. ((Holm et al., 2015); 
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doi:10.1371/journal.pone.0125495) under the terms of the Creative Commons 980 
Attribution Licence 4.0 (http://creativecommons.org/licenses/by/4.0/).  
 
Fig. 3.  Neuropathology in the brains of mice with clinical prion disease.  Once the 
prions enter the CNS the characteristic neuropathology they cause includes 
neurodegeneration (vacuolation in upper right-hand H&E images) and extensive 
microglial activation (Iba1, brown, lower panels).  Scale bars, 100 µm.   
 
Fig. 4.  Mononuclear phagocytes (MNP) in the lamina propria.  a) En-face, whole-
mount image of the lamina propria in the small intestine of a CSF1R-EGFP mouse.  
b) In the steady state the MNP are typically restrained within the lamina propria.  990 
c) In the presence of pathogenic microorganisms such as Salmonella or 
Aspergillus, MNP are recruited to the epithelium where they open the tight 
junctions between epithelial cells, enabling them to insert their dendrites directly 
into the lumen to sample the contents (Farache et al., 2013, Niess et al., 2005, 
Rescigno et al., 2001, Vallon-Eberhard et al., 2006). 
 
Fig. 5.  Oral infection of mice with the nematode parasite Trichuris muris causes 
pathology specifically within the caecum.  Mice were orally infected with 
approximately 200 infective T. muris eggs and tissues collected at the intervals 
indicated for further analysis.  a) T. muris establishes infection in the caecal 1000 
epithelium.  Left-hand panels show autofluorescent immature worms adhered to 
the caecal epithelium in whole-mount prepared tissue specimens.  Arrowheads, 
ILF (B220+ cells, green).  H&E image shows the close association of T. muris with 
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the caecal epithelium/lamina propria (arrows) and sites of damage the parasite 
causes to the gut epithelium.  b) Pieces of ileum and caecum were collected at 
intervals after T. muris exposure and immunostained to detect macrophages 
(CD11b+ cells, green).  T. muris infection stimulates the influx of macrophages into 
the lamina propria of the caecum, but not in the ileum of the small intestine.  c)  
The distal 8 cm of ileum and the entire caecum from control mice, or T. muris-
infected mice (28 days post-infection), were whole-mount immunostained to detect 1010 
isolated lymphoid follicles (individual B cell follicles; B220+ cells; green).  This 
analysis shows that T. muris infection stimulates the development of abundant 
isolated lymphoid follicles (arrows) in caecum.  In the ileum, in contrast, the number 
and density of isolated lymphoid follicles was unchanged after T. muris infection.  
Figure adapted from Donaldson et al. (Donaldson et al., 2015b), copyright © 
American Society for Microbiology, J. Virol. (2015) 89:9532–9547. 
doi:10.1128/JVI.01544-15. 
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Table 1. Prion diseases of humans and animals 1020 
Prion disease Affected 
Species 
Route of Transmission 
Iatrogenic Creutzfeldt-
Jacob disease 
Human Accidental medical exposure to CJD-
contaminated tissues or tissue 
products 
Sporadic Creutzfeldt-
Jacob disease  
Human Unknown. Theories include somatic 
mutation or spontaneous conversion of 
PrPc to PrPSc 
Variant Creutzfeldt-
Jacob disease 
Human Ingestion of BSE-contaminated food or 
transfusion of blood or blood products 
from CJD-infected blood donor 
Familial Creutzfeldt-
Jacob disease 
Human Germ-line mutations of the PRNP gene
Gerstmann-
Straussler-Scheinker 
syndrome 
Human Germ-line mutations of the PRNP gene
Kuru Human  Ritualistic cannibalism 
Fatal familial 
insomnia 
Human Germ-line mutations of the PRNP gene
Bovine spongiform 
encephalopathy 
Cattle Ingestion of contaminated food 
Scrapie Sheep, 
goats, 
mouflon 
Acquired. Ingestion, horizontal 
transmission, vertical transmission 
unclear 
Chronic wasting 
disease 
Elk, deer, 
moose 
Acquired, ingestion, horizontal 
transmission, vertical transmission 
unclear 
Transmissible mink 
encephalopathy 
Mink Acquired (ingestion) source unknown 
Feline spongiform 
encephalopathy 
Domestic 
and 
zoological 
cats 
Ingestion of BSE-contaminated food 
Exotic ungulate 
encephalopathy 
Nyala, kudu,  Ingestion of BSE-contaminated food 
 
Abbreviations used: BSE, bovine spongiform encephalopathy; CJD, Creutzfeldt-
Jakob disease; PRNP, the gene that encodes PrPc. 
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Table 2. Congruent infection with the natural mouse, large intestinal, helminth 
pathogen Trichuris muris does not influence oral prion disease pathogenesis* 
 
 
 
 
 
 
 
Conditions 
 
 
Day post-T. 
muris infection 
when mice 
were orally 
infected with 
prions† 
 
 
 
 
Pathological effects of 
T. muris-infection on 
large intestine 
 
 
 
Mean prion 
disease 
duration 
(days±SE) 
 
 
 
 
 
Disease 
incidence‡ 
 
Prions only 
 
 
none 
 
none 
 
343 ± 9 
 
8/8 
T. muris + prions 0 none 350 ± 7 7/7 
 
T. muris + prions 
 
+7 
 
Damage to gut 
epithelium 
 
  356 ± 12 
 
7/7 
 
T. muris + prions 
 
+21 
 
Influx of intra-
epithelial 
macrophages 
 
  356 ± 13 
 
8/8 
 
T. muris + prions 
 
+42 
 
Approx. 7 d after T. 
muris expulsion 
 
 
  347 ± 4 
 
 
7/7 
 
* Data adapted from Donaldson et al. (Donaldson et al., 2015b).   
† Mice were orally-infected with T. muris and subsequently orally-exposed to ME7 
scrapie prions on the days indicated. 1030 
‡ Incidence = no. animals displaying clinical signs of prion disease/no. animals 
tested.   
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Table 3. Prion disease in two independent studies using germ-free mice 
 
 
Mouse 
microbiological 
status 
 
Route of 
prion 
infection 
 
Mean prion 
disease 
duration (days) 
 
 
Disease 
incidence‡ 
 
 
 
Study 
 
 
Reported 
P value 
 
Conventional* 
 
 
IC 
 
N/A 
 
15/18 
 
(Lev et al., 
1971) 
 
 
Germ-free IC N/A 8/19  >0.05 
 
 
 
Defined flora† 
 
 
 
IC 
 
 
 
151 
 
   
 
N/A 
 
 
 
(Wade et 
al., 1986) 
 
 
 
 
Germ-free IC 148 N/A 
   
 
 
NS 
 
Defined flora IP 190 
 
N/A 
 
  
Germ-free 
 
IP 249 N/A  0.05 
 
* In the Lev study mice were observed for clinical signs of prion disease up to 23 1040 
weeks after exposure (Lev et al., 1971).   
† In the Wade study the effects in germ-free were compared to those colonized 
with a restricted, defined Gram-positive bacterial flora comprising of particular 
species of Clostridium, Bacillus, Lactobacillus and Bacteroides (Wade et al., 
1986). 
‡ Incidence = no. animals culled due to clinical signs of prion disease/no. animals 
tested.   
Abbreviations used: IC, intracerebral; IP, intraperitoneal; N/A, insufficient data 
reported. 
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